The staff of the Royal College of London was made a discovery in the field of genetics. Scientists have long been engaged in the problems of the development of AIDS and HIV, the mechanism of the origin, development tools against this disease. The human immunodeficiency virus (HIV) is a disaster in developing countries, can be transmitted sexually or from mother to child, through used needles and syringes. The disease is associated with the inhibition of the cellular immune system. The number of CD4 lymphocytes in the disease process rapidly decreases with the barrier function of the body that ceases to resist even the most simple of infection (influenza, SARS, fungi).
Scientists have moved to a new level of understanding of HIV: a gene that is responsible for the body's resistance to this virus and provides a stop its spread to internal environments, writes The Indian Express.
The gene is called MX2 and inhibits the human immunodeficiency virus that leads to the development of the most severe phase of AIDS. Scientists believe that this finding can serve as a basis for developing more effective means against the disease, which will act faster and in smaller dosages.
The experiments say that the presence of MX2 makes the cells more resistant to HIV, while its absence leads to increased chance of infection.
The study's author, Professor Mike Malin argues that the opening MX2 gene is a new step in understanding the mechanisms of disease development. In the future it will be possible to develop tools that activate the internal forces of the body to fight disease. Medicines for HIV are highly toxic, although it can significantly prolong life. In addition, they are addictive which is why every time requires higher and higher doses to maintain the effectiveness of therapy.